Drew S. Kern

Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease

Danna Jennings, Sarah Huntwork‐Rodriguez, Anastasia G. Henry et al. · Science Translational Medicine · 2022 · 252 citations

Life Sciences, Neuroscience, Pharmacology +17

Long-term activity in upper- and lower-limb muscles of humans

Drew S. Kern, John G. Semmler, Roger M. Enoka · Journal of Applied Physiology · 2001 · 134 citations

Life Sciences, Anatomy, Physiology +16

Biocompatibility of poly(ethylene glycol)‐based hydrogels in the brain: An analysis of the glial response across space and time

Kimberly B. Bjugstad, Kyle J. Lampe, Drew S. Kern et al. · Journal of Biomedical Materials Research Part A · 2010 · 116 citations

Engineering, Bioengineering, Neuroscience +17

Biocompatibility of PEG-Based Hydrogels in Primate Brain

Kimberly B. Bjugstad, D. Eugene Redmond, Kyle J. Lampe et al. · Cell Transplantation · 2008 · 101 citations · Full text

Natural Sciences, Bioengineering, Neuroscience +17

Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease

Christopher H. Gibbons, Ningshan Wang, Sharika Rajan et al. · Neurology · 2023 · 98 citations · Full text

Life Sciences, Neurology, Neuroscience +17